LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 128

Search options

  1. Article: Molecular Characteristics and Prevalence of Rifampin Resistance in

    Kim, Yong Kyun / Eom, Yewon / Kim, Eunsil / Chang, Euijin / Bae, Seongman / Jung, Jiwon / Kim, Min Jae / Chong, Yong Pil / Kim, Sung-Han / Choi, Sang-Ho / Lee, Sang-Oh / Kim, Yang Soo

    Antibiotics (Basel, Switzerland)

    2023  Volume 12, Issue 10

    Abstract: Rifampin resistance (RIF-R) ... ...

    Abstract Rifampin resistance (RIF-R) in
    Language English
    Publishing date 2023-10-04
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2681345-2
    ISSN 2079-6382
    ISSN 2079-6382
    DOI 10.3390/antibiotics12101511
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Correction to: Protracted course of SARS‑CoV‑2 pneumonia in moderately to severely immunocompromised patients.

    Lee, Jeongjae / Kim, A Reum / Kang, Sung Woon / Chang, Euijin / Bae, Seongman / Jung, Jiwon / Kim, Min Jae / Chong, Yong Pil / Lee, Sang-Oh / Choi, Sang-Ho / Kim, Yang Soo / Kim, Sung-Han

    Clinical and experimental medicine

    2023  Volume 23, Issue 6, Page(s) 2265

    Language English
    Publishing date 2023-02-04
    Publishing country Italy
    Document type Published Erratum
    ZDB-ID 2053018-3
    ISSN 1591-9528 ; 1591-8890
    ISSN (online) 1591-9528
    ISSN 1591-8890
    DOI 10.1007/s10238-023-01016-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Comparison of the Clinical Outcomes Between Early and Delayed Transplantation After SARS-CoV-2 Infection.

    Ra, Sang Hyun / Kim, A Reum / Jang, Hyeon Mu / Chang, Euijin / Bae, Seongman / Jung, Jiwon / Kim, Min Jae / Chong, Yong Pil / Lee, Sang-Oh / Choi, Sang-Ho / Kim, Yang Soo / Kim, Sung-Han

    Journal of Korean medical science

    2024  Volume 39, Issue 14, Page(s) e137

    Abstract: Our study analyzed 95 solid organ transplant (SOT) and 78 hematopoietic stem cell transplant (HSCT) recipients with prior coronavirus disease 2019 (COVID-19). Patients who underwent transplantation within 30 days of COVID-19 infection comprised the early ...

    Abstract Our study analyzed 95 solid organ transplant (SOT) and 78 hematopoietic stem cell transplant (HSCT) recipients with prior coronavirus disease 2019 (COVID-19). Patients who underwent transplantation within 30 days of COVID-19 infection comprised the early group, and those who underwent transplantation post-30 days of COVID-19 infection comprised the delayed group. In the early transplantation group, no patient, whether undergoing SOT and HSCT, experienced COVID-19-associated complications. In the delayed transplantation group, one patient each from SOT and HSCT experienced COVID-19-associated complications. Additionally, among early SOT and HSCT recipients, two and six patients underwent transplantation within seven days of COVID-19 diagnosis, respectively. However, no significant differences were observed in the clinical outcomes of these patients compared to those in other patients. Early transplantation following severe acute respiratory syndrome coronavirus 2 infection can be performed without increased risk of COVID-19-associated complications. Therefore, transplantation needs not be delayed by COVID-19 infection.
    MeSH term(s) Humans ; COVID-19 Testing ; COVID-19 ; SARS-CoV-2 ; Organ Transplantation ; Transplant Recipients
    Language English
    Publishing date 2024-04-15
    Publishing country Korea (South)
    Document type Journal Article
    ZDB-ID 639262-3
    ISSN 1598-6357 ; 1011-8934
    ISSN (online) 1598-6357
    ISSN 1011-8934
    DOI 10.3346/jkms.2024.39.e137
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Comparison of the clinical and virological characteristics of SARS-CoV-2 Omicron BA.1/BA.2 and omicron BA.5 variants: A prospective cohort study.

    Kang, Sung-Woon / Park, Heedo / Kim, Ji Yeun / Lim, So Yun / Lee, Sohyun / Bae, Joon-Yong / Kim, Jeonghun / Chang, Euijin / Bae, Seongman / Jung, Jiwon / Kim, Min Jae / Chong, Yong Pil / Lee, Sang-Oh / Choi, Sang-Ho / Kim, Yang Soo / Park, Man-Seong / Kim, Sung-Han

    The Journal of infection

    2023  Volume 86, Issue 5, Page(s) e148–e151

    MeSH term(s) Humans ; SARS-CoV-2 ; Prospective Studies ; COVID-19 ; Antibodies, Neutralizing ; Antibodies, Viral
    Chemical Substances Antibodies, Neutralizing ; Antibodies, Viral
    Language English
    Publishing date 2023-01-18
    Publishing country England
    Document type Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 424417-5
    ISSN 1532-2742 ; 0163-4453
    ISSN (online) 1532-2742
    ISSN 0163-4453
    DOI 10.1016/j.jinf.2023.01.015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Corrigendum to "Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection" [J Infect 85 (2022) e69-e71].

    Kang, Sung Woon / Kim, Ji Yeun / Park, Heedo / Lim, So Yun / Kim, Jeonghun / Bae, Seongman / Jung, Jiwon / Kim, Min Jae / Chong, Yong Pil / Lee, Sang-Oh / Choi, Sang-Ho / Kim, Yang Soo / Park, Man-Seong / Kim, Sung-Han

    The Journal of infection

    2023  Volume 87, Issue 2, Page(s) e42–e43

    Language English
    Publishing date 2023-05-25
    Publishing country England
    Document type Published Erratum
    ZDB-ID 424417-5
    ISSN 1532-2742 ; 0163-4453
    ISSN (online) 1532-2742
    ISSN 0163-4453
    DOI 10.1016/j.jinf.2023.05.015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Transmission Characteristics of SARS-CoV-2 That Hinder Effective Control.

    Bae, Seongman / Lim, Joon Seo / Kim, Ji Yeun / Jung, Jiwon / Kim, Sung-Han

    Immune network

    2021  Volume 21, Issue 1, Page(s) e9

    Abstract: The most important characteristics of coronavirus disease 2019 (COVID-19) transmission that makes it difficult to control are 1) asymptomatic and presymptomatic transmission, 2) low incidence or lack of dominant systemic symptoms such as fever, 3) ... ...

    Abstract The most important characteristics of coronavirus disease 2019 (COVID-19) transmission that makes it difficult to control are 1) asymptomatic and presymptomatic transmission, 2) low incidence or lack of dominant systemic symptoms such as fever, 3) airborne transmission that may need a high infectious dose, and 4) super-spread events (SSEs). Patients with COVID-19 have high viral loads at symptom onset or even a few days prior to symptom onset, and most patients with COVID-19 have only mild respiratory symptoms or merely pauci-/null-symptoms. These characteristics of the virus enable it to easily spread to the community because most patients are unaware of their potential infectivity, and symptom-based control measures cannot prevent this type of transmission. Furthermore, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is also capable of airborne transmission in conditions such as aerosol-generating procedures, under-ventilated indoor spaces, and over-crowded areas. In this context, universal mask-wearing is important to prevent both outward and inward transmission until an adequate degree of herd immunity is achieved through vaccination. Lastly, the SSEs of SARS-CoV-2 transmission emphasize the importance of reducing contacts by limiting social gatherings. The above-mentioned transmission characteristics of SARS-CoV-2 have culminated in the failure of long-lasting quarantine measures, and indicate that only highly effective vaccines can keep the communities safe from this deadly, multifaceted virus.
    Language English
    Publishing date 2021-02-22
    Publishing country Korea (South)
    Document type Journal Article ; Review
    ZDB-ID 2536191-0
    ISSN 2092-6685 ; 1598-2629
    ISSN (online) 2092-6685
    ISSN 1598-2629
    DOI 10.4110/in.2021.21.e9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Comparison of the causes of death associated with delta and Omicron SARS-CoV-2 variants infection

    A Reum Kim / Jiyoung Lee / Somi Park / Sung Woon Kang / Yun Woo Lee / So Yun Lim / Euijin Chang / Seongman Bae / Jiwon Jung / Min Jae Kim / Yong Pil Chong / Sang-Oh Lee / Sang-Ho Choi / Yang Soo Kim / Sung-Han Kim

    Journal of Infection and Public Health, Vol 16, Iss 1, Pp 133-

    2023  Volume 135

    Keywords Coronavirus ; COVID-19 ; SARS-CoV-2 ; Delta ; Omicron ; Cause of death ; Infectious and parasitic diseases ; RC109-216 ; Public aspects of medicine ; RA1-1270
    Language English
    Publishing date 2023-01-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: Routine ophthalmologic examination in

    Lim, So Yun / Kwon, Hye Ji / Lee, Yun Woo / Sung, Heungsup / Kim, Mi-Na / Chang, Euijin / Bae, Seongman / Jung, Jiwon / Kim, Min Jae / Kim, Sung-Han / Choi, Sang-Ho / Lee, Sang-Oh / Kim, Yang Soo / Lee, Joo Yong / Chong, Yong Pil

    Antimicrobial agents and chemotherapy

    2023  Volume 67, Issue 11, Page(s) e0082223

    Abstract: Klebsiella ... ...

    Abstract Klebsiella pneumoniae
    MeSH term(s) Humans ; Klebsiella pneumoniae ; Incidence ; Retrospective Studies ; Klebsiella Infections/drug therapy ; Klebsiella Infections/epidemiology ; Anti-Bacterial Agents/therapeutic use ; Liver Abscess/drug therapy ; Endophthalmitis/drug therapy ; Endophthalmitis/epidemiology ; Chorioretinitis/complications ; Chorioretinitis/drug therapy ; Bacteremia/epidemiology ; Risk Factors
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2023-10-24
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 217602-6
    ISSN 1098-6596 ; 0066-4804
    ISSN (online) 1098-6596
    ISSN 0066-4804
    DOI 10.1128/aac.00822-23
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Comparison of the rapidity of SARS-CoV-2 immune responses between primary and booster vaccination for COVID-19.

    Kim, Ji Yeun / Kwon, Ji-Soo / Cha, Hye Hee / Lim, So Yun / Bae, Seongman / Kim, Sung-Han

    The Korean journal of internal medicine

    2022  Volume 37, Issue 6, Page(s) 1234–1240

    Abstract: Background/aims: The rapidity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific memory B or T cell response in vaccinated individuals is important for our understanding of immunopathogenesis of coronavirus disease 2019 (COVID-19). ...

    Abstract Background/aims: The rapidity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific memory B or T cell response in vaccinated individuals is important for our understanding of immunopathogenesis of coronavirus disease 2019 (COVID-19). We therefore compared the timing of adequate immune responses between the first and booster doses of COVID-19 vaccines in infection-naïve healthcare workers.
    Methods: We enrolled healthcare workers who received two doses of either the BNT162b2 vaccine or the ChAdOx1 vaccine, all of whom received the BNT162b2 vaccine as the booster (the third) dose. Spike 1 (S1)-immunoglobulin G (IgG) antibodies and interferon gamma producing T cell responses were measured at 0, 7, 14, and 21 days after the first dose, and at 0 and between 2 to 7 days after the booster dose.
    Results: After the first-dose vaccination, the S1-IgG antibody responses were elicited within 14 days in the BNT162b2 group and within 21 days in the ChAdOx1 group. After the booster dose, the S1-IgG antibody responses were elicited within 5 days in both groups. The SARS-CoV-2-specific T cell responses appeared at 7 days after the first dose and at 4 days after the booster dose.
    Conclusion: SARS-CoV-2-specific immune responses by memory B cells and T cells may be expected to appear around 4 to 5 days after the booster dose.
    MeSH term(s) Humans ; BNT162 Vaccine ; COVID-19/prevention & control ; COVID-19 Vaccines ; Immunity ; Immunoglobulin G ; SARS-CoV-2 ; Vaccination ; Viral Vaccines
    Chemical Substances BNT162 Vaccine ; COVID-19 Vaccines ; Immunoglobulin G ; Viral Vaccines
    Language English
    Publishing date 2022-10-11
    Publishing country Korea (South)
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 639023-7
    ISSN 2005-6648 ; 1226-3303
    ISSN (online) 2005-6648
    ISSN 1226-3303
    DOI 10.3904/kjim.2022.173
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Comparison of antibody responses after the 1st and 2nd doses of COVID-19 vaccine with those of patients with mild or severe COVID-19

    Hye Hee Cha / So Yun Lim / Ji-Soo Kwon / Ji Yeun Kim / Seongman Bae / Jiwon Jung / Sung-Han Kim

    The Korean Journal of Internal Medicine, Vol 37, Iss 2, Pp 455-

    2022  Volume 459

    Abstract: Background/Aims Data comparing the antibody responses of different coronavirus disease 2019 (COVID-19) vaccine platforms according to dose with natural severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection-induced antibody responses are ... ...

    Abstract Background/Aims Data comparing the antibody responses of different coronavirus disease 2019 (COVID-19) vaccine platforms according to dose with natural severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection-induced antibody responses are limited. Methods Blood samples from adult patients with mild and severe COVID-19 and healthcare workers who received ChAdOx1 nCoV-19 vaccine (2nd dose at 12-week intervals) and BNT162b2 vaccine (2nd dose at 3-week intervals) were collected and compared by immunoglobulin G immune responses to SARS-CoV-2 specific spike protein using an in-house-developed enzyme-linked immunosorbent assay. Results A total of 53 patients, including 12 and 41 with mild and severe COVID-19, respectively, were analyzed. In addition, a total of 73 healthcare workers, including 37 who received ChAdOx1 nCoV-19 and 36 who received BNT162b2, were enrolled. Antibody responses after the first and second doses of the ChAdOx1 nCoV-19 vaccine or the first dose of the BNT162b2 vaccine were similar to those in convalescent patients with mild COVID-19, but lower than those in convalescent patients with severe COVID-19, respectively. However, after the second dose of the BNT162b2 vaccine, the antibody response was comparable to that in convalescent patients with severe COVID-19. Conclusions Our data suggest that the second dose of mRNA vaccination may be more beneficial in terms of long-term immunity and prevention of SARS-CoV-2 variant infection than a single dose of COVID-19 vaccination or homologous second challenge ChAdOx1 nCoV-19.
    Keywords sars-cov-2 ; vaccines ; antibody formation ; Medicine ; R
    Subject code 610 ; 616
    Language English
    Publishing date 2022-03-01T00:00:00Z
    Publisher The Korean Association of Internal Medicine
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top